How Addressing Inefficiency in Health Systems Could Spur Innovation and Provide Real Value to Patients

Published Nov 5, 2019

Efficiences in Health SystemCopenhagen, Denmark—5 November 2019—ISPOR, the professional society for health economics and outcomes research—explored the issue of wasted healthcare spending and how to improve health system efficiencies in the session, “How Can We Create Headroom for High-Value Care By Increasing Efficiency in Health Systems?” [IP9]. The session was held this morning at ISPOR Europe 2019 in Copenhagen, Denmark.

The Organisation for Economic Co-operation and Development (OECD) reports that up to one-fifth of healthcare spending is wasted (eg, through unnecessary treatments, delayed discharges, or errors) and so makes no meaningful contribution to health outcomes. If these wasted resources could be identified, released, and reallocated, it could have a significant impact on stretched healthcare budgets.

Panelists for this session included:

  • Maria Errea, PhD; Office of Health Economics, London, England, UK
  • Stefan Gijssels, MA, Digestive Cancers Europe, Brussels, Belgium
  • Douglas Gregory, MBA, Amgen and Chair of the EFPIA Healthcare Systems Working Group, Brussels, Belgium
  • Carlos Mur, MD, PhD, Sociedad Española de Directivos de la Salud, Madrid, Spain

The panel discussed a series of innovative case studies that cover sources of inefficiency across different health systems in Europe. Case studies included screening, procurement, and use of biosimilars to demonstrate how inefficiencies can arise. They explored a variety of potential solutions examined the magnitude of benefit that could be achieved through reductions in inefficiency.

Addressing and correcting inefficiency in health systems could allow for improvements in health, quality of life, and quality of healthcare without increasing expenditures. Increased efficiency could also spur innovation and high-value interventions and bring real value for patients.

ISPOR is recognized globally as the leading professional society for health economics and outcomes research and its role in improving healthcare decisions. ISPOR Europe 2019 expects to draw more than 5000 healthcare stakeholders with an interest in HEOR, including researchers and academicians, assessors and regulators, payers and policymakers, the life sciences industry, healthcare providers, and patient engagement organizations.

Additional information on the conference can be found at:
Conference Information | Program and Presentations | #ISPOREurope | Sponsors | Exhibitors | News and Press

###

ABOUT ISPOR
ISPOR, the professional society for health economics and outcomes research (HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE®-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field.
Web: www.ispor.org | LinkedIn: www.linkedin.com/company/ispororg | Twitter: www.twitter.com/ispororg (@ISPORorg) | YouTube: www.youtube.com/ispororg | Facebook: www.facebook.com/ispororg | Instagram: www.instagram.com/ispororg

Related Stories

ISPOR Europe 2019 Convened More Than 5500 Healthcare Stakeholders in the Society’s Largest Conference To Date

Nov 7, 2019

ISPOR concluded its ISPOR Europe 2019 conference yesterday in Copenhagen, Denmark. The conference convened more than 5500 global healthcare stakeholders and HEOR thought leaders representing more than 90 countries. The record attendance of ISPOR Europe 2019 marks the Society’s largest conference to date.

Big Data Offer Opportunity for Research and Learning in Healthcare

Nov 6, 2019

ISPOR its third plenary session at ISPOR Europe 2019, “Big Data Healthcare: Endless Opportunities for Research and Learning," this morning in Copenhagen, Denmark.

Is the Subscription-Based Model for Drug Reimbursement the Future?

Nov 6, 2019

ISPOR explored the topical issue of the subscription-based model for drug reimbursement this morning during the session, “Subscription-Based Model for Drug Reimbursement: A Fad or the Future?”, at ISPOR Europe 2019 in Copenhagen, Denmark.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×